美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

美国抗疫概念

1,327.58

-9.1315-0.68%

涨家数：5

跌家数：15

平家数：- -

市盈率：- -

高：1,343.21

开：1,342.69

低：1,326.57

收：1,336.71

数据加载中...

总览新闻资讯

背景资料-欧洲企业因经济放缓而裁员

Moderna 联合疫苗遇阻：研发调整与市场考量下的艰难前行

生物制品圈

Arvinas 裁员33%，与辉瑞终止多项乳腺癌 3 期试验

生物制品圈

据英国《金融时报》报道，J&J支持的HistoSonics公司探讨以25亿美元的估值出售HistoSonics公司

速递｜砍掉神经管线，阿斯利康彻底转向专注于减肥与免疫赛道

GLP1减重宝典

吉利德科学5月1日成交额为7.55亿美元

阿斯利康5月1日成交额为4.09亿美元

BUZZ-莫德纳下跌，因为该公司预计 FDA 将推迟批准流感-COVID复合疫苗

Equillium, Inc.盘中异动早盘大幅上涨7.09%

Co-Diagnostics, Inc.盘中异动早盘快速上涨5.41%

吉利德科学盘中异动早盘股价大跌3.03%报103.31美元

诺瓦瓦克斯医药盘中异动早盘股价大跌5.10%报6.33美元

伊诺维奥制药盘中异动早盘股价大跌5.67%报1.83美元

Moderna(MRNA.O)首席财务官：目前关税没有显著的直接影响。

莫德纳称 FDA 具有建设性，但推迟注射流感/COVID 疫苗

Haleon 预测中期利润将以高个位数百分比增长

莫德纳第一季度利润和销售额超出华尔街预期

辉瑞4月30日成交额为13.08亿美元

77亿美元，辉瑞又开始省钱了

莫德纳4月30日成交额为2.18亿美元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK4568/news?page=5&region=SGP"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"美国抗疫概念","latestPrice":1327.5806,"timestamp":1746820799999,"preClose":1336.712,"halted":0,"volume":113582454,"delay":0,"changeRate":-0.006831,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":-9.13147,"latestTime":"05-09 16:00:00 EDT","open":1342.69,"high":1343.2052,"low":1326.5701,"amount":4653162209.902576,"amplitude":0.012445,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1747036800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.565313,"peRate":21.186942,"turnoverRate":0.007317,"increases":5,"decrements":15,"flats":0,"marketCap":1093969830401.5,"floatMarketCap":1075897192963},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1343.2052,"amplitude":0.012445,"preClose":1336.712,"low":1326.5701,"pbRate":"3.565313","latestPrice":1327.5806,"volume":113582454,"delay":0,"open":1342.69,"prevYearClose":1274.8187,"prevWeekClose":1375.2667,"prevMonthClose":1374.5028,"prevQuarterClose":1427.887,"fiveDayClose":1375.2667,"twentyDayClose":1281.7616,"sixtyDayClose":1380.7908,"secType":"PLATE","market":"US","turnoverRate":0.007317,"peRate":21.186942,"marketCap":1093969830401.5,"floatMarketCap":1075897192963,"timestamp":1746820799999,"nameCN":"美国抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":5,"down":15,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532810560","title":"背景资料-欧洲企业因经济放缓而裁员","url":"https://stock-news.laohu8.com/highlight/detail?id=2532810560","media":"路透中文","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532810560?lang=zh_cn&edition=fundamental","pubTime":"2025-05-02 19:39","pubTimestamp":1746185966,"startTime":"0","endTime":"0","summary":"路透5月2日 - 严峻的经济形势和对许多产品持续疲软的需求迫使欧洲各地的公司冻结招聘或裁员。* 雷诺rena.pa：这家法国汽车制造商于 3 月 11 日表示， ，将在桑杜维尔的面包车工厂裁员 300 人，以应对欧洲商用车需求的放缓。* 蒂森克虏伯 tkag.de：这家德国企业集团于 3 月 6 日表示，由于其供应的汽车行业长期疲软，计划裁员约 1800 人， 。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250502:nL4T3RA182:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4535","BK4588","BK4139","BK4551","BK4548","BNTX","BK4568"],"gpt_icon":0},{"id":"2532894406","title":"Moderna 联合疫苗遇阻：研发调整与市场考量下的艰难前行","url":"https://stock-news.laohu8.com/highlight/detail?id=2532894406","media":"生物制品圈","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532894406?lang=zh_cn&edition=fundamental","pubTime":"2025-05-02 14:31","pubTimestamp":1746167470,"startTime":"0","endTime":"0","summary":"在疫苗研发领域，Moderna 公司一直备受瞩目。Moderna 决定降低针对 18 至 49 岁人群的 mRNA - 1083 研发优先级。较低的接种率意味着该年龄段市场潜力相对有限，这可能是 Moderna 做出调整的重要原因之一。成本削减与研发投入变化Moderna 此次对 mRNA - 1083 的调整，与公司削减运营成本的计划紧密相关。第一季度，Moderna 的研发成本下降了 19%，降至 8.56 亿美元 。Moderna 的流感 / 新冠联合疫苗 mRNA - 1083 所面临的困境，是众多疫苗研发企业可能面临问题的一个缩影。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502145310a6d0d262&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502145310a6d0d262&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4532","MRNA","BK4588","BK4501","BK4585","BK4568","BK4551","BK4548","BK4533","BK4534","CDC"],"gpt_icon":0},{"id":"2532891695","title":"Arvinas 裁员33%，与辉瑞终止多项乳腺癌 3 期试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2532891695","media":"生物制品圈","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532891695?lang=zh_cn&edition=fundamental","pubTime":"2025-05-02 14:31","pubTimestamp":1746167470,"startTime":"0","endTime":"0","summary":"近日，生物技术公司 Arvinas 在公布第一季度财报时，宣布了一系列重大调整举措。但在周四公布的项目最新进展中，Arvinas 表示，基于与卫生部门的沟通以及对其他生物标志物选择人群试验的观察，决定终止两项 3 期试验 。为此，Arvinas 决定裁员 33%。截至 3 月底，Arvinas 拥有 9.543 亿美元现金，这些调整预计将使公司资金使用周期延长至 2028 年下半年，而此前的计划是支撑到 2027 年。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502145331a46fb767&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502145331a46fb767&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0321505868.SGD","LU1883839398.USD","LU0306807586.USD","LU1057294990.SGD","SG9999013999.USD","SG9999001176.USD","IE000M9KFDE8.USD","LU0122379950.USD","BK4550","SG9999001176.SGD","IE00B19Z3B42.SGD","LU0985481810.HKD","BK4585","LU1066051498.USD","SG9999011175.SGD","LU0058720904.USD","IE00B19Z3581.USD","LU0170899867.USD","BK4599","SG9999002232.USD","LU0225771236.USD","IE00BLSP4452.SGD","LU0225284248.USD","LU1023059063.AUD","SG9999003800.SGD","IE0002270589.USD","BK4588","BK4533","LU1894683348.USD","IE00BBT3K403.USD","PFE","IE00BLSP4239.USD","LU0306806265.USD","BK4534","LU0868494617.USD","LU0456855351.SGD","BK4568","LU0234572021.USD","LU1894683264.USD","BK4581","BK4592","BK4007","SG9999002224.SGD","LU0289739699.SGD","LU1066053197.SGD","LU0321505439.SGD","SGXZ57979304.SGD"],"gpt_icon":1},{"id":"2532865792","title":"据英国《金融时报》报道，J&J支持的HistoSonics公司探讨以25亿美元的估值出售HistoSonics公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2532865792","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532865792?lang=zh_cn&edition=fundamental","pubTime":"2025-05-02 12:13","pubTimestamp":1746159237,"startTime":"0","endTime":"0","summary":"据英国《金融时报》报道，J&J支持的HistoSonics公司探讨以25亿美元的估值出售HistoSonics公司路透5月2日 - 英国《金融时报》周五援引知情人士的话报道称，强生JNJ.N支持的医疗技术公司HistoSonics在收到多起收购邀约后，正在探索潜在的出售方案。 报道称，该公司正在寻求超过25亿美元的估值。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250502:nL4S3RA0FW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","IE00BJJMRZ35.SGD","LU1894683348.USD","LU0882574055.USD","LU2430703178.SGD","BK4592","BK4007","SG9999002224.SGD","BK4568","LU0985320562.USD","IE00BFTCPJ56.SGD","LU0912757837.SGD","BK4550","BK4534","IE00B19Z3B42.SGD","LU1066051811.HKD","IE0034235303.USD","LU0320765646.SGD","LU1778281490.HKD","LU2430703095.HKD","JNJ","BK4559","LU2112291526.USD","IE00BBT3K403.USD","LU1074936037.SGD","IE00B3T34201.USD","LU0345770308.USD","LU1066051225.USD","LU0234572021.USD","IE00BDGV0183.EUR","LU0345770993.USD","IE00BVYPNW00.USD","IE00BGHQF631.EUR","IE00BLSP4239.USD","LU1506573853.SGD","LU0098860793.USD","LU1244550221.USD","LU0114720955.EUR","LU1732800096.USD","LU1718418525.SGD","IE00BJT1NW94.SGD","BK4533","LU1244550577.SGD","LU2089984988.USD","LU0795875169.SGD","LU2129689431.USD","LU0889566641.SGD","LU1267930813.SGD","LU2129689605.HKD","LU0203345920.USD"],"gpt_icon":0},{"id":"2532886623","title":"速递｜砍掉神经管线，阿斯利康彻底转向专注于减肥与免疫赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2532886623","media":"GLP1减重宝典","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532886623?lang=zh_cn&edition=fundamental","pubTime":"2025-05-02 11:44","pubTimestamp":1746157479,"startTime":"0","endTime":"0","summary":"整理 | GLP1减重宝典内容团队2025年4月29日，阿斯利康在发布2025年第一季度财报时宣布，将正式退出神经科学领域的研发工作，未来将更加专注于减重、免疫学等核心治疗方向。目前，阿斯利康在神经科学方向已无在研项目。目前，阿斯利康正在加快推进包括口服GLP-1药物和乳腺癌候选药物camizestrant在内的多个关键项目。此类策略有望缓解GLP-1类药物导致的肌肉流失问题，并进一步拓展治疗适应范围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502121759a46f9a32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502121759a46f9a32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","LU0889565916.HKD","BK4568","AZN","LU2417539215.USD","LU2456880835.USD","LU2462157665.USD","LU2236285917.USD","LU0320765992.SGD","BK4007","LU1829250122.USD","BK4588","LU0109394709.USD"],"gpt_icon":0},{"id":"2532851905","title":"吉利德科学5月1日成交额为7.55亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532851905","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532851905?lang=zh_cn&edition=fundamental","pubTime":"2025-05-02 09:36","pubTimestamp":1746149798,"startTime":"0","endTime":"0","summary":"美东时间2025年5月1日，吉利德科学成交额为7.55亿美元，成交额较昨日减少25.78%，当日成交量为727.09万股。吉利德科学于2025年5月1日跌3.09%，报103.25美元，该股过去5个交易日跌2.73%，年初至今涨12.57%，过去60日涨6.11%。吉利德对Pharmasset的收购带来了丙型肝炎药物索磷布韦片的使用权，该药物也是仍为治疗标准的较新的联合方案的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502093645a46f7d25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502093645a46f7d25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B19Z3581.USD","IE00BKVL7J92.USD","IE00BSNM7G36.USD","BK4568","BK4578","LU0109394709.USD","LU2089984988.USD","LU0234570918.USD","LU1839511570.USD","LU2468319806.SGD","LU0889565916.HKD","BK4588","BK4550","LU0058720904.USD","LU0289739699.SGD","IE00B19Z3B42.SGD","LU2087621335.USD","BK4585","LU1066051498.USD","LU0320765992.SGD","LU1430594728.SGD","LU1066053197.SGD","BK4139","IE0002270589.USD","GILD","IE00B7SZLL34.SGD","LU1571399168.USD","BK4566","IE00B3T34201.USD","BK4532","IE00BZ1G4Q59.USD","LU1585245621.USD","BK4583"],"gpt_icon":0},{"id":"2532385934","title":"阿斯利康5月1日成交额为4.09亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532385934","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532385934?lang=zh_cn&edition=fundamental","pubTime":"2025-05-02 09:17","pubTimestamp":1746148629,"startTime":"0","endTime":"0","summary":"美东时间2025年5月1日，阿斯利康成交额为4.09亿美元，成交额较昨日增加40.45%，当日成交量为582.01万股。阿斯利康于2025年5月1日跌1.78%，报70.51美元，该股过去5个交易日涨1.38%，年初至今涨9.37%，过去60日涨3.83%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-01|4.09亿|40.45%|582.01万|#|2025-04-30|2.91亿|-48.32%|405.73万|#|2025-04-29|5.64亿|0.18%|791.91万|#|2025-04-28|5.63亿|21.81%|802.34万|#|2025-04-25|4.62亿|94.02%|666.27万|1999 年，瑞典阿斯特拉公司与英国捷利康集团合并，成立了阿斯利康公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502091717a46f7946&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502091717a46f7946&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4585","LU2236285917.USD","LU2462157665.USD","LU0109394709.USD","LU0889565916.HKD","LU0320765992.SGD","AZN","LU1829250122.USD","BK4568","LU2456880835.USD","LU2417539215.USD","BK4588"],"gpt_icon":0},{"id":"2532075430","title":"BUZZ-莫德纳下跌，因为该公司预计 FDA 将推迟批准流感-COVID复合疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=2532075430","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532075430?lang=zh_cn&edition=fundamental","pubTime":"2025-05-02 00:04","pubTimestamp":1746115461,"startTime":"0","endTime":"0","summary":"** 包括本交易日的走势在内，该股今年累计下跌 33.9(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nL4S3R91P2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4551","BK4585","BK4139","BK4532","MRNA","BK4501","BK4588","BK4533","BK4568","BK4534"],"gpt_icon":0},{"id":"2532400119","title":"Equillium, Inc.盘中异动 早盘大幅上涨7.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532400119","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532400119?lang=zh_cn&edition=fundamental","pubTime":"2025-05-01 22:20","pubTimestamp":1746109201,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日22时20分，Equillium, Inc.股票出现异动，股价快速上涨7.09%。Equillium, Inc.股票所在的生物技术行业中，整体跌幅为0.70%。Equillium, Inc.公司简介：Equillium Inc是一家临床阶段的生物技术公司，致力于开发新的治疗方法，以治疗严重的自身免疫性和炎症性疾病，或免疫炎症性疾病，具有高度未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501222001a46efb8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501222001a46efb8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","EQ","BK4139"],"gpt_icon":0},{"id":"2532095390","title":"Co-Diagnostics, Inc.盘中异动 早盘快速上涨5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532095390","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532095390?lang=zh_cn&edition=fundamental","pubTime":"2025-05-01 22:09","pubTimestamp":1746108551,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日22时09分，Co-Diagnostics, Inc.股票出现异动，股价急速拉升5.41%。Co-Diagnostics, Inc.股票所在的医疗器械行业中，整体跌幅为0.27%。其相关个股中，Nanovibronix, Inc.、Trisalus Life Sciences Inc C/Wts 10/08/28 、Conmed Corporation涨幅较大，Nanovibronix, Inc.、Bluejay Diagnostics, Inc.、Invo Fertility, Inc.较为活跃，换手率分别为1974.05%、239.28%、181.41%，振幅较大的相关个股有Pulmonx Corporation、Nanovibronix, Inc.、Invo Fertility, Inc.，振幅分别为29.07%、20.10%、17.57%。Co-Diagnostics, Inc.公司简介：Co-Diagnostics Inc是一家分子诊断公司。该公司还利用其专有技术为其 Co-Dx PCR 平台设计特定测试，并定位用于传染病以外应用的遗传标记。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501220911974c9bfe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501220911974c9bfe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4082","CODX"],"gpt_icon":0},{"id":"2532008426","title":"吉利德科学盘中异动 早盘股价大跌3.03%报103.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532008426","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532008426?lang=zh_cn&edition=fundamental","pubTime":"2025-05-01 21:47","pubTimestamp":1746107241,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日21时47分，吉利德科学股票出现波动，股价快速下跌3.03%。截至发稿，该股报103.31美元/股，成交量56.4398万股，换手率0.05%，振幅2.34%。吉利德科学股票所在的制药行业中，整体跌幅为4.03%。消息层面，截至21时47分，《吉利德科学与美国政府达成2亿美元和解协议》资讯为影响吉利德科学的重要信息。曼哈顿联邦检察官指控，吉利德从2011年1月至2017年11月实施部分计划，以推广和增加其治疗艾滋病毒的药物的销售量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501214721974c9934&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501214721974c9934&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GILD","LU2089984988.USD","BK4568","BK4139","LU1571399168.USD","LU2468319806.SGD","IE00B19Z3581.USD","LU0058720904.USD","LU1839511570.USD","LU0109394709.USD","LU2087621335.USD","LU0289739699.SGD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","BK4566","IE00B7SZLL34.SGD","LU0889565916.HKD","LU1430594728.SGD","BK4588","BK4585","IE0002270589.USD","LU0320765992.SGD","LU0234570918.USD","IE00B3T34201.USD","LU1066053197.SGD","LU1585245621.USD","LU1066051498.USD","BK4583","BK4532","BK4550","BK4578"],"gpt_icon":0},{"id":"2532063340","title":"诺瓦瓦克斯医药盘中异动 早盘股价大跌5.10%报6.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532063340","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532063340?lang=zh_cn&edition=fundamental","pubTime":"2025-05-01 21:34","pubTimestamp":1746106443,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日21时34分，诺瓦瓦克斯医药股票出现波动，股价急速下挫5.10%。截至发稿，该股报6.33美元/股，成交量32.6836万股，换手率0.20%，振幅4.87%。机构评级方面，在所有7家参与评级的机构中，57%的券商给予买入建议，29%的券商给予持有建议，14%的券商给予卖出建议。诺瓦瓦克斯医药股票所在的生物技术行业中，整体跌幅为1.51%。公司认为其疫苗技术有潜力广泛应用于多种人类传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501213403aa2c805e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501213403aa2c805e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4547","NVAX","BK4568","BK4139","BK4585"],"gpt_icon":0},{"id":"2532008411","title":"伊诺维奥制药盘中异动 早盘股价大跌5.67%报1.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532008411","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532008411?lang=zh_cn&edition=fundamental","pubTime":"2025-05-01 21:33","pubTimestamp":1746106399,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日21时33分，伊诺维奥制药股票出现异动，股价快速下挫5.67%。截至发稿，该股报1.83美元/股，成交量6.5294万股，换手率0.18%，振幅4.64%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。伊诺维奥制药股票所在的生物技术行业中，整体跌幅为1.22%。伊诺维奥制药公司简介：Inovio Pharmaceuticals Inc 是一家总部位于美国的生物技术公司。该公司专注于开发和商业化 DNA 药物，以帮助治疗和保护人们免受 HPV 相关疾病、癌症和传染病的侵害。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501213319a46ef277&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501213319a46ef277&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","INO","BK4583","BK4568"],"gpt_icon":0},{"id":"2532071920","title":"Moderna(MRNA.O)首席财务官：目前关税没有显著的直接影响。","url":"https://stock-news.laohu8.com/highlight/detail?id=2532071920","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532071920?lang=zh_cn&edition=fundamental","pubTime":"2025-05-01 20:14","pubTimestamp":1746101693,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK4551","BK4585","BK4533","BK4534","BK4139","BK4568","MRNA","BK4548","BK4501","BK4588","BK4532"],"gpt_icon":0},{"id":"2532079864","title":"莫德纳 称 FDA 具有建设性，但推迟注射流感/COVID 疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=2532079864","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532079864?lang=zh_cn&edition=fundamental","pubTime":"2025-05-01 19:56","pubTimestamp":1746100614,"startTime":"0","endTime":"0","summary":"更新版 2-莫德纳 称 FDA 具有建设性，但推迟注射流感/COVID 疫苗莫德纳削减成本，业绩好于预期COVID 和流感疫苗的联合疗法预计要到 2026 年才能获批关税对 莫德纳 在美国生产的药品影响甚微第 1 段和第 4-7 段增加了公司评论以及与 FDA 交流的背景，第 3 段增加了分享内容Patrick Wingrove/Michael Erman. 公司的 Spikevax COVID 疫苗销售额为 8,400 万美元，RSV 疫苗 mRESVIA 的销售额为 200 万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nL4S3R90X8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","MRNA","BK4501","BK4533","BK4547","NVAX","BK4534","BK4588","BK4139","BK4568","BK4548","BK4532","BK4551"],"gpt_icon":0},{"id":"2532982076","title":"Haleon 预测中期利润将以高个位数百分比增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2532982076","media":"路透中文","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532982076?lang=zh_cn&edition=fundamental","pubTime":"2025-05-01 19:42","pubTimestamp":1746099771,"startTime":"0","endTime":"0","summary":"更新版 2-Haleon 预测中期利润将以高个位数百分比增长预计五年内可节约 8 亿英镑的生产成本杰富瑞分析师预计 2027 年盈利共识将上调 5股价上涨近 4第 7、9 和 10 段增加了分析师评论，第 3 段更新了股价，第 6 段增加了前景细节Pushkala Aripaka. 路透5月1日 - 感康牙膏生产商海伦HLN.L周四预测，受主要市场对其产品的稳定需求和供应链成本削减预期的帮助，从2026年起其利润将实现高个位数百分比的增长。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nL4T3R90VR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0306806265.USD","BK5011","IE0002270589.USD","IE000M9KFDE8.USD","BK4533","LU0456855351.SGD","LU1066051498.USD","BK4581","LU1023059063.AUD","IE00BLSP4452.SGD","LU0321505868.SGD","BK4007","IE00BBT3K403.USD","LU1057294990.SGD","LU0321505439.SGD","IE00B19Z3B42.SGD","LU1066053197.SGD","BK4550","BK5127","IE00B19Z3581.USD","LU0225771236.USD","BK4585","SG9999013999.USD","LU0868494617.USD","BK4588","LU1894683348.USD","LU1894683264.USD","SG9999002224.SGD","BK4534","BK4568","IE00BLSP4239.USD","LU0225284248.USD","LU1883839398.USD","BK4599","LU0985481810.HKD","SG9999003800.SGD","LU0170899867.USD","HLN.UK","SG9999011175.SGD","LU0234572021.USD","BK4592","LU0058720904.USD","LU0289739699.SGD","SGXZ57979304.SGD","SG9999002232.USD","LU0122379950.USD","SG9999001176.USD","LU0306807586.USD","SG9999001176.SGD"],"gpt_icon":1},{"id":"2532027491","title":"莫德纳 第一季度利润和销售额超出华尔街预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2532027491","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532027491?lang=zh_cn&edition=fundamental","pubTime":"2025-05-01 18:30","pubTimestamp":1746095404,"startTime":"0","endTime":"0","summary":"莫德纳 第一季度利润和销售额超出华尔街预期莫德纳削减成本，业绩好于预期COVID 和流感疫苗的联合疗法预计要到 2026 年才能获批关税对 莫德纳 在美国生产的药品影响甚微Patrick Wingrove. 路透5月1日 - 莫德纳 MRNA.O周四公布的第一季度利润和销售额超过了华尔街的预期，这得益于该公司在大流行后对其COVID-19疫苗的需求减弱后削减成本的努力。莫德纳重申其2025年全年产品销售额预期为15亿至25亿美元，其中大部分预计将在下半年实现。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nL4S3R90O1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4548","BK4588","BK4547","NVAX","BK4568","BK4532","MRNA","BK4551","BK4501","BK4139","BK4585","BK4533"],"gpt_icon":0},{"id":"2532904883","title":"辉瑞4月30日成交额为13.08亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532904883","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532904883?lang=zh_cn&edition=fundamental","pubTime":"2025-05-01 10:22","pubTimestamp":1746066146,"startTime":"0","endTime":"0","summary":"美东时间2025年4月30日，辉瑞成交额为13.08亿美元，成交额较昨日减少43.87%，当日成交量为5394.17万股。辉瑞于2025年4月30日涨2.61%，报24.41美元，该股过去5个交易日涨9.02%，年初至今跌6.47%，过去60日跌6.83%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-30|13.08亿|-43.87%|5394.17万|#|2025-04-29|23.31亿|80.85%|9854.02万|#|2025-04-28|12.89亿|57.16%|5588.89万|#|2025-04-25|8.20亿|3.34%|3584.77万|#|2025-04-24|7.94亿|-30.67%|3500.96万|辉瑞是全球最大的制药公司之一，年销售额接近500亿美元。辉瑞在全球销售这些产品，国际销售额占其总销售额的近50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501102235a46e7041&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501102235a46e7041&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE000M9KFDE8.USD","LU0234572021.USD","LU1066051498.USD","LU0225284248.USD","LU0456855351.SGD","IE00BLSP4452.SGD","BK4592","LU0170899867.USD","SG9999003800.SGD","SG9999001176.SGD","LU1057294990.SGD","LU1894683348.USD","LU0058720904.USD","LU1023059063.AUD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","BK4599","IE0002270589.USD","LU1066053197.SGD","LU0306807586.USD","SG9999002224.SGD","SG9999001176.USD","SG9999011175.SGD","IE00B19Z3581.USD","BK4533","BK4550","PFE","SG9999013999.USD","BK4007","LU1894683264.USD","LU0122379950.USD","LU0306806265.USD","BK4534","LU1883839398.USD","LU0289739699.SGD","LU0868494617.USD","LU0321505439.SGD","LU0321505868.SGD","IE00BBT3K403.USD","SGXZ57979304.SGD","BK4585","BK4581","LU0225771236.USD","BK4588","LU0985481810.HKD","BK4568","SG9999002232.USD"],"gpt_icon":1},{"id":"2532026633","title":"77亿美元，辉瑞又开始省钱了","url":"https://stock-news.laohu8.com/highlight/detail?id=2532026633","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532026633?lang=zh_cn&edition=fundamental","pubTime":"2025-05-01 10:09","pubTimestamp":1746065340,"startTime":"0","endTime":"0","summary":"辉瑞公布2025年第一季度财报，总营收137亿美元，同比下降8%，主要原因是新冠药物Paxlovid销售额下降。研发费用支出也减少12%。辉瑞重申全年收入预计在610亿至640亿美元之间，并宣布新的成本削减计划，预计到2027年节省77亿美元开支。辉瑞通过自动化和人工智能等数字工具以及简化业务流程来实现成本节约，并计划从研发经费中砍掉5亿美元用于重新投资研发管线。在全球医药市场竞争激烈、成本压力上升的背景下，其他跨国药企如百时美施贵宝和赛诺菲也在实施大规模重组和裁员计划以降低成本。这些措施包括优化组织架构、减少层级、提高决策效率和整合职能，以应对行业挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050116092294e9c6ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050116092294e9c6ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BLSP4452.SGD","SG9999003800.SGD","IE000M9KFDE8.USD","BK4592","LU0225771236.USD","LU1023059063.AUD","LU1066051498.USD","LU0122379950.USD","BK4581","LU0456855351.SGD","BK4588","LU0058720904.USD","BK4599","IE0002270589.USD","LU0306806265.USD","PFE","LU0321505439.SGD","BK4568","LU1057294990.SGD","LU0868494617.USD","IE00B19Z3B42.SGD","SG9999011175.SGD","IE00B19Z3581.USD","BK4585","LU1894683348.USD","LU0170899867.USD","LU1883839398.USD","LU0985481810.HKD","SG9999001176.USD","SGXZ57979304.SGD","LU1894683264.USD","BK4550","SG9999002232.USD","LU0234572021.USD","LU0321505868.SGD","IE00BBT3K403.USD","SG9999002224.SGD","SG9999013999.USD","BK4533","LU0306807586.USD","LU0289739699.SGD","SG9999001176.SGD","BK4007","BK4534","LU0225284248.USD","IE00BLSP4239.USD","LU1066053197.SGD"],"gpt_icon":0},{"id":"2532010573","title":"莫德纳4月30日成交额为2.18亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532010573","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532010573?lang=zh_cn&edition=fundamental","pubTime":"2025-05-01 10:05","pubTimestamp":1746065106,"startTime":"0","endTime":"0","summary":"美东时间2025年4月30日，莫德纳成交额为2.18亿美元，成交额较昨日增加49.72%，当日成交量为772.99万股。莫德纳于2025年4月30日涨2.59%，报28.54美元，该股过去5个交易日涨7.54%，年初至今跌31.36%，过去60日跌21.92%。该公司的 mRNA 技术通过其 COVID-19 疫苗迅速得到验证，该疫苗于 2020 年 12 月在美国获得批准。截至 2024年9月，莫德纳拥有处于临床试验中的40个mRNA开发候选物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501100514a6cf8dc7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501100514a6cf8dc7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4551","MRNA","BK4548","BK4533","BK4568","BK4501","BK4585","BK4588","BK4532","BK4139","BK4534"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":5,"totalSize":174,"code":"91000000","status":"200"}]}}